Skip to content

F-Prime Capital

  • People
  • Portfolio
  • Impact
Search
  • Home
  • People
  • Portfolio
    • Life Sciences
    • Technology
    • Healthtech + Services
    • Crypto
  • Impact
  • About
  • Jobs
  • Fintech Index

Singular Genomics

NASDAQ: OMIC
Developing advanced DNA sequencing solutions though genomics technology.
Developing advanced DNA sequencing solutions though genomics technology.
Singular Genomics

F-Prime Team

Robert Weisskoff, Ph.D.
Carlos Bustamante, Ph.D.
Jessica Alston, Ph.D.
Kevin Chu

Sector

Life Sciences

Category

Medtech

Location

La Jolla, CA

Initial Investment

2019
Singular Genomics

Singular Genomics (NASDAQ: OMIC) is developing a new next generation sequencing platform.
singulargenomics.com
Jobs

Life Sciences
Technology
Healthtech + Services
Crypto

About
Jobs
Fintech Index

LinkedIn
X

Cambridge
1 Main St. 13th Floor
Cambridge, MA 02142
London
33 Foley Street
London, W1W 7TL
San Francisco
140 New Montgomery Street
2nd Floor, Suite A
San Francisco, CA 94105

Get the latest updates in healthcare and technology:

Subscribe

We respect your privacy.

The information on these pages is intended solely for the benefit of entrepreneurs seeking venture capital investments. F-Prime is not offering investment advisory services nor is it offering to sell securities. F‑Prime provides advisory services as Impresa Management LLC. The list of portfolio companies includes investments made by Fidelity Ventures and Eight Roads. FBRI is an affiliate of F‑Prime and a subsidiary of FMR LLC. As of July 1, 2024, F-Prime advises Fine Structure Ventures (finestructure.vc).

©2025 F-Prime    Terms of Use    Privacy Policy

close
close
Sign up to get the latest updates from F-Prime:
We respect your privacy.